|
NT5C2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.48540000000231E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.015780E-04 |
| Normal-vs-Stage2 |
6.098200E-02 |
| Normal-vs-Stage3 |
3.483100E-03 |
| Normal-vs-Stage4 |
4.230400E-04 |
| Stage1-vs-Stage2 |
7.284600E-01 |
| Stage1-vs-Stage3 |
6.008200E-01 |
| Stage1-vs-Stage4 |
3.869000E-01 |
| Stage2-vs-Stage3 |
5.005800E-01 |
| Stage2-vs-Stage4 |
2.947400E-01 |
| Stage3-vs-Stage4 |
6.209000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.91789999999648E-05 |
| Normal-vs-AfricanAmerican |
3.277800E-03 |
| Normal-vs-Asian |
3.279800E-01 |
| Caucasian-vs-AfricanAmerican |
8.215200E-01 |
| Caucasian-vs-Asian |
5.383400E-01 |
| AfricanAmerican-vs-Asian |
5.957600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.72369999957334E-07 |
| Normal-vs-Female |
5.197400E-01 |
| Male-vs-Female |
2.261200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.164300E-04 |
| Normal-vs-Extreme_Weight |
7.0899000004232E-07 |
| Normal-vs-Obese |
1.863300E-03 |
| Normal-vs-Extreme_Obese |
1.012140E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.827000E-01 |
| Normal_Weight-vs-Obese |
4.298800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.271200E-01 |
| Extreme_Weight-vs-Obese |
1.505640E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.260200E-01 |
| Obese-vs-Extreme_Obese |
7.041400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.125800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.480590E-03 |
| Normal-vs-Age(61-80Yrs) |
2.17549999999012E-05 |
| Normal-vs-Age(81-100Yrs) |
2.081600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.814100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.430340E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.920500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.296810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.917510E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.811830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.163230E-04 |
| Normal-VS-Type2 PRCC |
6.5548999561571E-10 |
| Normal-VS-KIRP CIMP |
3.732600E-01 |
| Normal-VS-Unclassified PRCC |
2.422600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.389400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.018300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.036560E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.97908999999274E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.043680E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
1.383810E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.27920000003723E-06 |
| Normal-vs-N1 |
6.684200E-02 |
| Normal-vs-N2 |
3.824700E-03 |
| N0-vs-N1 |
5.314100E-02 |
| N0-vs-N2 |
5.680000E-01 |
| N1-vs-N2 |
2.140400E-01 |
|
|
